Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Seagen Inc.
Pfizer
Baylor College of Medicine
Children's Cancer Group, China
Cellectar Biosciences, Inc.
Stichting Hemato-Oncologie voor Volwassenen Nederland
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Centre Henri Becquerel
University of Chicago
M.D. Anderson Cancer Center
City of Hope Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
GlaxoSmithKline
Takeda
Baylor College of Medicine
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Immunitas Therapeutics
University of Colorado, Denver
Dana-Farber Cancer Institute
Centre Leon Berard
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Memorial Sloan Kettering Cancer Center
Children's National Research Institute
University of Washington
City of Hope Medical Center
Baylor College of Medicine
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center